Spinal cord-injured (SCI) patients often suer from symptomatic polymicrobial urinary tract infection (UTI). The objective of this study was to evaluate the clinical outcome and costsavings associated with antibiotic therapy based on limited vs full microbiological investigation of urine cultures in adult SCI patients with symptomatic polymicrobial UTI (52 organisms growing in urine cultures). In the ®rst part of the study, a total of 40 evaluable patients were prospectively randomized in a single-blinded fashion to receive antibiotic therapy based on either limited (21 patients) or full microbiologic investigation (19 patients) of urine cultures. The practicality of a limited microbiological investigation was further examined in the second part of the study where 12 consecutive patients with symptomatic polymicrobial UTI initially had only limited microbiological investigation of urine cultures and received antibiotic therapy accordingly. When analyzing all patients in the study, the likelihood of adequate clinical response was not signi®cantly dierent between those who received antibiotic therapy based on limited (28/33=85%) vs full (18/19=95%) microbiological investigation of urine cultures (P=0.40). An average of 183 US dollars could be saved per patient by managing symptomatic polymicrobial UTI based on a limited vs a full microbiological investigation. These results suggest that in adult SCI patients with symptomatic polymicrobial UTI antibiotic therapy guided by a limited microbiological investigation may be practical, adequate and cost-saving.
Introduction
Patients with spinal cord injury (SCI) commonly suer from a neuropathic bladder and become dependent on bladder catheterization. By bypassing the urethra, the most eective defense mechanism against infection, placement of a catheter into the bladder has a high risk of introducing bacteria into the urinary tract. 1 Although the risk of developing bacteriuria may be lower in SCI patients who undergo intermittent catheterization of the bladder than those with indwelling bladder catheters, urinary tract infection (UTI) represents the most common infection in both groups of patients. 2 It is not surprising, therefore, that urine specimens constitute the largest number of specimens collected from SCI patients and processed at most clinical microbiology laboratories. 3 It is generally reported that about 11 ± 31% of hospitalized patients with symptomatic UTI have polymicrobial growth in urine cultures. 4 ± 7 An even greater portion of SCI patients with clinical UTI are thought to have polymicrobial urine cultures. For instance, almost half of positive urine cultures from SCI patients with clinical UTI in our institution were observed to grow 52 organisms in urine cultures; this ®nding is usually referred to as polymicrobial symptomatic UTI, although not all cultured organisms may contribute to signs and symptoms of UTI. There is no established way to accurately identify which cultured organism(s) is/are responsible for the particular clinical episode of polymicrobial UTI, 7 thereby impairing the ability to administer antibiotic therapy directed against only the pathogenic organism(s). As a result, physicians generally request that clinical microbiology laboratories identify and perform antibiotic susceptibility on most, if not all, organisms isolated from urine cultures in patients with polymicrobial UTI. This management approach is expensive and labor-intensive and usually leads to the administration of a broad-spectrum antibiotic regimen that can possibly be associated with an increased risk of developing adverse drug eects and bacterial resistance.
Another potential approach in patients with symptomatic polymicrobial UTI entails administration of antibiotic therapy guided by limited investigation of urine cultures and monitoring the clinical response of patients. Institution of processing controls for investigation of polymicrobial urine cultures at a clinical microbiology laboratory has been reported to reduce the laboratory costs. 3, 8 However, the clinical impact on patient care and the overall savings attributed to guiding antibiotic therapy for symptomatic polymicrobial UTI by only a limited microbiological investigation of urine cultures have not been previously examined, particularly in the population of SCI patients in whom symptomatic UTI is often polymicrobial.
The two main objectives of this study were to: (1) compare the outcome of symptomatic polymicrobial UTI in adult SCI patients who receive antibiotic therapy guided by a limited vs a full microbiological investigation of urine cultures; and (2) determine the cost-savings that result from the use of the former vs the latter approach for managing symptomatic polymicrobial UTI in this population.
Materials and methods

Patient population
Male patients who suered from symptomatic polymicrobial UTI while hospitalized at the 40-bed SCI Unit at the Veterans Aairs Medical Center, Houston, Texas, USA, were eligible for enrollment in this study. An informed consent was obtained for all enrolled patients. Symptomatic polymicrobial UTI was de®ned by the presence of polymicrobial bacteriuria (52 bacterial species growing from urine cultures, each at a concentration of 510 3 cfu/ml) and pyuria (55 WBC/HPF), in association with one or more of the following clinical manifestations, including fever, ank or suprapubic tenderness, bladder spasm, dysuria, change in voiding habits, nausea or vomiting, increase in spasticity, worsening of dysre¯exia, and leukocytosois; other potential etiologies for these clinical manifestations had to be excluded before symptomatic UTI could be diagnosed.
Study design: ®rst part
This study consisted of two parts. The ®rst part was a prospective, randomized, single-blinded study. Patients enrolled into the ®rst part of the study were randomized into one of two groups (group A or B). Patients in group A received empirical antibiotic therapy guided by the information provided by limited microbiologic investigation of urine cultures, including colony morphology, appearance on Gram-stain, catalase test, and oxidase test (identi®cation of organisms and their antibiotic susceptibilities were not performed). These tests helped identify the group of organisms to which the isolated bacteria belong and, therefore, helped narrow down the selection of empirical antibiotics based on the recognized hospital-based patterns of antibiotic susceptibilities for various groups of organisms. Patients randomized to group B received susceptibility-guided antibiotic therapy based on the information provided by complete microbiological investigation of urine cultures. Identi®cation of bacteria and antibiotic susceptibilities were accomplished by standard bacteriologic methods. 9 Although a complete microbiological investigation was performed on urine cultures from all patients enrolled in both groups A and B, the results of the complete microbiologic investigation were generally not made available to the physicians who treated patients belonging to group A. Only in instances where patients belonging to group A had not responded to their assigned empirical antibiotic therapy were the results of a complete microbiological investigation made known to the respective physicians. Patients belonging to group A or B were managed by the same group of primary care physicians.
Patients who were clinically judged to be too sick to await the results of the limited or full microbiological investigation of urine cultures were started by the primary care physicians on initial pre-investigation antibiotic therapy sometime after obtaining the urine cultures. When the results of the microbiological investigation became available, patients were managed according to one of three scenarios: (1) freshly started on the assigned form of antibiotic therapy; (2) kept on the same pre-investigation antibiotic regimen that had been initially started (in this case, the day of starting the assigned therapy is considered as that day when initial pre-investigation therapy was started before receiving the results of the microbiological investigation of urine cultures); or (3) switched from the initial pre-investigation antibiotic regimen to the assigned form of therapy (if the initial pre-investigation antibiotic regimen was judged to lack coverage against 51 of the originally isolated organisms).
Patients with the clinical diagnosis of lower UTI received a one-week course of assigned antibiotics (usually per mouth, except if the results of antibiotic susceptibility testing indicated the need for parenteral agents). Subjects with the clinical diagnosis of pyelonephritis (re¯ected by the presence of¯ank pain or tenderness, nausea, vomiting, signs of clinical sepsis, or associated bacteremia) were treated with antibiotics for 2 weeks (usually with parenteral agents during the ®rst week and with oral agents thereafter). Patients were monitored at 3 ± 4 days after initiation of antibiotic therapy and within a day of completing the assigned antibiotic therapy. Monitoring consisted of evaluation of the clinical manifestations of UTI, analysis of pyuria and performance of urine cultures. Adequate response to therapy was de®ned as clinical improvement within 3 ± 4 days of instituting the assigned antibiotic therapy and which persisted throughout the duration of treatment. Failure to respond to therapy was de®ned by either: (a) the lack of clinical improvement after 3 ± 4 days of receiving assigned antibiotic therapy, or (b) the persistence of some signs and symptoms of UTI at end of treatment, in association with persistent pyuria and bacteriuria due to 51 of the originally isolated organisms. In order to compare the potential impact of antibiotic therapy guided by limited vs full microbiologic investigation on the recurrence of symptomatic UTI, patients were monitored for recurrence of symptomatic UTI due to 51 of the originally isolated bacterial species over a period of 1 month after the end of the assigned antibiotic therapy.
Study design: second part
The second part of the study was designed to examine the practicality of treating a consecutive sample of SCI patients suering from symptomatic polymicrobial UTI with empirical antibiotic therapy guided by a limited microbiological investigation. Only limited microbiologic investigation was initially performed on urine cultures obtained from patients enrolled into this part of the study, and the bacterial plates were saved at 48C; in patients who failed to respond to empirical antibiotic therapy, bacterial plates were retrieved from the refrigerator and the identities and antibiotic susceptibilities of the isolated organisms were determined. Clinical monitoring of patients participating in this part of the study was performed in a fashion similar to that of the ®rst part of the study.
Cost analysis
The overall costs of managing symptomatic polymicrobial UTI in SCI patients based on a limited vs a full microbiological investigation were assessed by determining: (1) the overall costs of antibiotic therapy, including costs of antibiotic acquisition, preparation, and administration (including personnel time and intravenous sets); and (2) the extra costs charged by a commercial laboratory for conducting a full vs a limited microbiological investigation of the collected polymicrobial urine cultures.
Statistical analysis
All evaluable patients enrolled into both parts of the study were aggregated for the sake of statistical analysis. Categorical variables were analyzed using either the Chi-square or Fisher's exact test. Continuous variables were compared using the t-test. A P value 50.05 was considered to be signi®cant. We assumed that ®nding 420% dierence in response rates among patients who have only a limited microbiological investigation vs a full microbiological investigation of polymicrobial urine cultures would certainly be clinically important. For instance, using a 2-tailed test and a=0.05, the power of this relatively small study for demonstrating a signi®cant dierence between an expected response rate of 95% (this response rate was anticipated from our own experience with this particular patient population) among patients who receive antibiotic therapy based on a full microbiological investigation of polymicrobial urine cultures vs a rate of 65% among patients who had only a limited microbiological evaluation would have been 81%.
Results
Clinical characteristics A total of 45 SCI patients were enrolled into the ®rst part of the study. Five patients were excluded from analysis because of either co-occurrence of other infections that impaired the ability to clearly evaluate the adequacy of clinical reponse of UTI to the assigned antibiotics (3 patients) or lack of adequate follow-up (two patients). Of the 40 evaluable patients enrolled into the ®rst part of the study, 21 received empirical antibiotic therapy based on a limited microbiological investigation and 19 were treated with antibiotics based on susceptibility patterns. All 12 SCI patients enrolled into the second part of the study were evaluable. The clinical characteristics of all evaluable patients who received empirical antibiotic therapy based on a limited microbiological investigation (a total of 33 patients) and of patients who were treated with antibiotics based on susceptibility patterns (19 patients) were compared in Table 1 . The two groups of male patients were well matched as to age, type of bladder drainage, location of UTI, route of administration of antibiotics, initiation of pre-investigation antibiotic therapy before the results of the microbiological investigation became available, isolation of 5 multiresistant urinary organism(s), and number of bacterial species isolated from urine cultures.
Response to therapy
As Table 2 shows, it took a signi®cantly shorter period of time after obtaining urine cultures to start the assigned antibiotic therapy based on a limited vs a full microbiological investigation of urine cultures (mean+SD of 1.2+1.4 days vs 3.3+2.5 days, respectively; P=0.01). Among those who had initially received pre-investigation antibiotic therapy prior to obtaining results of urine cultures, a signi®cantly higher number of patients who had a limited vs a full microbiological investigation of urine cultures required no change in antibiotic therapy after obtaining culture results (85% vs 33%, respectively; P=0.006). Clinical response was not signi®cantly dierent between those who received antibiotic therapy guided by limited vs full microbiological investigation (85% vs 95%; P=0.40).
All ®ve patients (three enrolled into the ®rst part of the study and two enrolled into the second part of the study) who had failed to clinically improve after 3 ± 4 days of receiving the assigned antibiotic therapy for UTI (one case had pyelonephritis) based on a limited microbiological investigation responded adequately when switched to susceptibility-based antibiotic therapy without any residual complications of UTI. The organisms that had not been covered by the originally assigned antibiotic regimens and, therefore, were thought to have been associated with inadequate clinical response included Citrobacter freundii (at a concentration 410 5 cfu/ml) in one case, Enterobacter aerogenes (at a concentration 410 5 cfu/ml) in one case, Providencia rettgeri (at a concentration 410 4 but 510 5 cfu/ml) in one case, a combination of Escherichia coli and Staphylococcus aureus (both at a concentration 410 5 cfu/ml) in one case, and a combination of S. aureus, Enterococcus faecalis and group B Streptococcus species (all at a concentration 510 5 cfu/ml) in the ®fth case. The only patient who failed to respond to the assigned susceptibility-based antibiotic therapy had a persistent infection by Providencia stuartii (at a concentration 410 5 cfu/ml) that became resistant to the assigned antibiotic (gentamicin); selection of another susceptibility-based antibiotic (cefotaxime) eventually cleared this symptomatic infection.
Urine cultures obtained at the end of therapy grew yeast in 3/33 (9%) patients who were treated based on a limited microbiological investigation vs 3/19 (16%) patients who received susceptibility-based antibiotic therapy (P=0.66). Recurrence of symptomatic UTI due to 51 of the originally infecting bacterial species within a month of discontinuing the assigned antibiotic therapy was equally observed in the two groups of patients (8/33=24% vs 4/19=21%, respectively; P=1.0).
Cost comparison
The mean overall cost of antibiotic therapy tended to be lower in patients in whom selection of antibiotic therapy was based on a limited (157+174; range, 0.1 ± 560 US dollars) vs full (252+237; range, 0.1 ± 882 US dollars) microbiological investigation of urine cultures; the dierence (mean, 95 US dollars), however, was not statistically signi®cant (P=0.18). The mean extra amount of money charged by a commercial laboratory to perform a full vs a limited microbiological investigation was 88 US dollars for each polymicrobial urine culture. (12) 4 (12) 13 (68) 
Discussion
The ®ndings of this study suggest that empirical antibiotic therapy guided by a limited microbiological investigation of urine cultures may be as eective as susceptibility-based antibiotic therapy for symptomatic polymicrobial UTI in male SCI patients. In the rare occasions (15% of cases) when such an approach failed to produce an adequate clinical response, further evaluation of organisms isolated from the agar plates that had been saved in the refrigerator provided the necessary antibiograms for initiation of susceptibilitybased antibiotic therapy that was regularly curative without any residual complications of UTI. Failure to respond to empirical therapy guided by a limited microbiological investigation of polymicrobial urine cultures could have been caused by the lack of antibiotic coverage for 51 implicated urinary pathogens. In agreement with previous reports, 7,10 ± 12 neither the type (both Gram-positive and -negative bacteria were implicated pathogens) nor the concentration (some pathogenic bacteria were present at concentrations 510 5 cfu/ml) of organisms in urine could help dierentiate in this study between pathogenic and colonizing bacteria. The ®ndings of similar occurrences of fungal superinfection and UTI relapse in patients who received antibiotic therapy guided by limited vs full microbiological investigation of urine cultures may yield further support to the adequacy of the former management approach.
In addition to possibly providing an adequate clinical response in SCI patients with symptomatic polymicrobial UTI, the ®ndings of this study suggest that empirical antibiotic therapy guided by a limited microbiological investigation of urine cultures can also be practical and cost-saving. This approach was associated with a quicker initiation of appropriate therapy and a lower likelihood for changing the initially instituted pre-investigation antibiotic regimen in patients who required treatment before investigating urine cultures. In other words, the institution of such an approach may facilitate the management and speed-up the appropriate disposition of patients. Although dierences were not statistically signi®cant, patients who received antibiotic therapy based on a full microbiological investigation were more likely to receive intravenous antibiotics. These dierences could not have been caused by dierences in the frequency of isolation of multiresistant urinary pathogens between the two groups of patients, but could have been attributed to the fact that administration of susceptibility-guided antibiotic therapy necessitated the use of intravenous antibiotics even in patients who could have tolerated oral therapy. Mean total savings of 183 US dollars per patient, equivalent to the sum of the extra laboratory charges for a full vs a limited microbiological investigation of polymicrobial urine cultures (mean, 88 US dollars) and the dierence in the overall costs of antibiotic therapy in patients whose therapy is guided by a full vs a limited microbiological investigation (mean, 95 US dollars), could be anticipated from using this management approach.
In subjects with a functional bladder urine cultures that yield polymicrobial growth are usually regarded as contaminated specimens and discarded, and repeat urine cultures are frequently requested. However, polymicrobial urine cultures can sometimes represent a true infection as demonstrated by the simultaneous growth of 51 identical organisms in blood and urine cultures from patients with urosepsis 13 or by the repeated growth of the same mixture of organisms in multiple urine specimens. 7 Our ®ndings support the notion that polymicrobial growth in urine cultures obtained from symptomatic SCI patients can be clinically meaningful. The results of this study may apply to other types of patients who are dependent on bladder catheterization, such as stroke victims, elderly subjects, and nursing home residents.
Conclusions
The ®ndings of this study suggest that the treatment of symptomatic polymicrobial UTI in adult SCI patients with empirical antibiotic therapy guided initially by a limited microbiological investigation may be adequate, practical, and cost-saving. Knowledge of the hospitalbased patterns of antibiotic susceptibilities for various groups of organisms is essential for the success of this approach. Bacterial plates can be initially saved in the refrigerator and, in patients who fail to improve after 3 ± 4 days of such antibiotic therapy, retrieved later for identi®cation and antibiograms of all isolated organisms. The utility of this management approach merits further examination in larger-sized clinical trials in SCI patients as well as in other subjects who require continuous bladder drainage.
